InsidersTradesSigma
Browse the complete record of transactions filed by Blackman Samuel C., Directeur Médical. Insider active across 1 companies, notably Day One Biopharmaceuticals, Inc.. Cumulatively, 5 filings have been logged. Total volume traded: €977k. The latest transaction was disclosed on 15 June 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
5 of 5 declarations
Samuel C. Blackman is the Chief Medical Officer at Day One Biopharmaceuticals, Inc. He is responsible for the medical direction of the company, overseeing research and development initiatives. His expertise in the medical field is essential for guiding drug development projects and ensuring regulatory compliance.